Angela Lamarca: “To do” or “not to do” maintenance chemotherapy in Biliary Malignancies
Angela Lamarca, Consultant in Medical Oncology at Jiménez Díaz Foundation University Hospital, posted on X about recent paper by her as first author, titled “Maintenance chemotherapy in biliary tract tumours in the era of immuno-chemotherapy” published on ESMO Gastrointestinal Oncology.
Authors: A. Lamarca, J. Adeva, I. Ales Díaz, R. Alvarez Gallego, A.J. Muñoz Martín, and T. Macarulla Mercade.
“‘To do’ or ‘not to do’ maintenance chemotherapy in Biliary Malignancies.
Our thoughts finally published in ESMO Gastrointestinal Oncology.“
Angela Lamarca, MD, PhD, MSc, is a Consultant in Medical Oncology at Jiménez Díaz Foundation University Hospital and The Christie NHS Foundation Trust. She also serves as an Honorary Consultant in Medical Oncology and Honorary Senior Lecturer at The University of Manchester. Dr. Lamarca specializes in gastrointestinal malignancies, particularly hepato-pancreato-biliary (HPB) cancers and neuroendocrine tumors (NETs).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023